Integrative genomic and immune landscape analysis of intimal sarcomas for emerging therapeutic targets and immunotherapy strategies
Our findings provided basic evidence for immunotherapy efficacy in intimal sarcomas and identified potential molecular targets. Further studies involving larger case series are required to validate these results.
Authors
- Alice Frazão Costa
- Gianluca Folesani (ORCID: https://orcid.org/0000-0001-8440-7411)
- Maria Concetta Nigro (ORCID: https://orcid.org/0000-0003-3834-6122)
- Maria Abbondanza Pantaleo (ORCID: https://orcid.org/0000-0002-0177-6957)
- Luisa Di Sciascio (ORCID: https://orcid.org/0000-0003-1809-3826)
- Luca Bergamaschi (ORCID: https://orcid.org/0000-0001-8186-9717)
- Ilenia Motta (ORCID: https://orcid.org/0000-0002-3137-1811)
- Chiara Baldovini (ORCID: https://orcid.org/0000-0002-1499-4654)
- Livia Gozzellino
- Margherita Nannini
- Francesco Angeli (ORCID: https://orcid.org/0000-0002-8732-4512)
- Carmine Pizzi
- Luigi Lovato
- Barbara Corti
- Gianandrea Pasquinelli
- Davide Pacini
- Annalisa Astolfi
Institutions
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Azienda USL di Bologna (IT)
- Ospedale G.B. Morgagni - L.Pierantoni (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-03-03
- DOI
- https://doi.org/10.3389/fimmu.2026.1723978
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission